Summit Therapeu ADR
(NQ:
SMMT
)
19.96
+0.01 (+0.05%)
Streaming Delayed Price
Updated: 10:18 AM EDT, Oct 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
453,597
Open
19.55
Bid (Size)
19.90 (16)
Ask (Size)
19.95 (16)
Prev. Close
19.95
Today's Range
19.55 - 20.33
52wk Range
1.640 - 33.89
Shares Outstanding
97,381,774
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Better Biotech Stock to Buy With $1,500 Right Now: Viking Therapeutics vs. Summit Therapeutics
October 13, 2024
It's hard to go wrong with either company, but one is more appealing.
Via
The Motley Fool
3 Things You Need to Know If You Buy Summit Therapeutics Stock Today
October 12, 2024
It's easier to invest confidently when you know both the pros and the cons in full.
Via
The Motley Fool
Performance
YTD
+656.06%
+656.06%
1 Month
-37.49%
-37.49%
3 Month
+110.77%
+110.77%
6 Month
+446.10%
+446.10%
1 Year
+1040.57%
+1040.57%
More News
Read More
(SMMT) - Analyzing Summit Therapeutics's Short Interest
October 10, 2024
Via
Benzinga
2 Soaring Stocks That Could Climb Another 112% and 120%, According to Wall Street Analysts
October 07, 2024
Via
The Motley Fool
Coinbase, Nike And Moderna Are Among Top 11 Large Cap Losers Last Week (Sept 30-Oct 4): Are The Others In Your Portfolio?
October 06, 2024
Via
Benzinga
Is Summit Therapeutics a Millionaire Maker?
October 05, 2024
Via
The Motley Fool
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 04, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
Could Summit Therapeutics Become the Next Merck?
October 04, 2024
Via
The Motley Fool
Why Phoenix Motor Shares Are Trading Higher By 150%; Here Are 20 Stocks Moving Premarket
October 04, 2024
Via
Benzinga
Summit Therapeutics Announces Completion of Enrollment in Its Phase III HARMONi Trial in 2L+ EGFRm NSCLC
October 03, 2024
From
Summit Therapeutics Inc.
Via
Business Wire
Where Will Summit Therapeutics Be in 3 Years?
October 03, 2024
Via
The Motley Fool
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In September 2024 – Where Do Tesla, Nvidia, Apple, DJT Stock Rank?
October 02, 2024
Via
Benzinga
Has Summit Therapeutics Stock Already Peaked?
October 02, 2024
Via
The Motley Fool
Is Summit Therapeutics Stock a Buy?
September 30, 2024
Via
The Motley Fool
Regeneron Pharma, Super Micro Computer And Global Payments Are Among Top 10 Large Cap Losers Last Week (Sept 23-Sept 27): Are The Others In Your Portfolio?
September 29, 2024
Via
Benzinga
2 High-Potential Growth Stocks You Shouldn't Overlook
September 29, 2024
Via
The Motley Fool
Better Rising Biotech: Viking Therapeutics vs. Summit Therapeutics
September 28, 2024
Via
The Motley Fool
2 Stocks Up Over 700% in 2024 That Could Soar Even Further
September 25, 2024
Via
The Motley Fool
Novo Nordisk, Chewy And FedEx Are Among Top 10 Large Cap Losers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
September 22, 2024
Via
Benzinga
This Stock Is Crushing Nvidia's Performance This Year: Is It Too Late to Buy?
September 22, 2024
Via
The Motley Fool
Industry Update: 3 Exciting Precision Oncology Players to Watch Following Summit’s Meteoric Rise: Silexion, Nuvectis, Scorpian
September 19, 2024
Via
AB Newswire
Industry Update: 3 Exciting Precision Oncology Players to Watch Following Summit’s Meteoric Rise: Silexion, Nuvectis, Scorpian
September 19, 2024
Via
News Direct
Is It Too Late to Buy Summit Therapeutics Stock After Its Almost 10X Gain This Year?
September 19, 2024
Via
The Motley Fool
This Company Generates No Revenue and Its Market Cap Is Over $20 Billion. Here's Why That Valuation May Not Be All That Ridiculous.
September 18, 2024
Via
The Motley Fool
How BioNTech, Up 25% Over Four Days, Is Riding Summit's Coattails To A Recovery
September 17, 2024
Via
Investor's Business Daily
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.